Murdoch Travis
CEO and President
Murdoch Travis has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 7, 2026.
On the most recent filing, Murdoch Travis is listed as CEO and President at Braveheart Bio, Inc. Inside the rolling window, Murdoch Travis reported 1 open-market purchase totaling $1.5M in BRVE and no open-market sales.
Companies traded
Other insiders at BRVE
Insider Buying
$1.5M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Murdoch Travis made?
Murdoch Travis has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Murdoch Travis trade?
Murdoch Travis has filed SEC Form 4 disclosures for 1 company, including BRVE.
When was Murdoch Travis's most recent SEC Form 4 filing?
Murdoch Travis's most recent SEC Form 4 filing on Tracefour is dated Aug 7, 2026.
What is Murdoch Travis's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Murdoch Travis is listed as CEO and President.
What is Murdoch Travis's total buy and sell value in the current window?
Inside the rolling retention window, Murdoch Travis bought $1.5M and sold $0 based on SEC Form 4 filings.
What was Murdoch Travis's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 83,333 BRVE shares on 2026-08-07, worth $1.5M, per SEC Form 4 filings.